Cardiac surgery outcomes in patients with coronavirus disease 2019 (COVID-19): A case-series report.


Journal

The Journal of thoracic and cardiovascular surgery
ISSN: 1097-685X
Titre abrégé: J Thorac Cardiovasc Surg
Pays: United States
ID NLM: 0376343

Informations de publication

Date de publication:
03 2022
Historique:
received: 19 05 2020
revised: 24 09 2020
accepted: 28 09 2020
pubmed: 23 11 2020
medline: 24 2 2022
entrez: 22 11 2020
Statut: ppublish

Résumé

The impact of coronavirus disease 2019 (COVID-19) on the postoperative course of patients after cardiac surgery is unknown. We experienced a major severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak in our cardiac surgery unit, with several patients who tested positive early after surgery. Here we describe the characteristics, postoperative course, and laboratory findings of these patients, along with the fate of the health care workers. We also discuss how we reorganize and reallocate hospital resources to resume the surgical activity without further positive patients. After diagnosis of the first symptomatic patient, surgery was suspended. Nasopharyngeal swabs were performed in all patients and health care workers. Patients who were positive for SARS-CoV-2 were isolated and monitored throughout the in-hospital stay and followed up after discharged until death or clinical recovery. Twenty patients were found to be positive for SARS-CoV-2 sometime after cardiac surgery (mean age 69 ± 10.4 years; median European System for Cardiac Operative Risk Evaluation II score 3 [interquartile range, 5.1]); the median time from surgery to diagnosis was 15 days (interquartile range, 11). Among the patients, 18 had undergone cardiac surgery and 2 of them transcatheter aortic valve replacement. Overall mortality was 15%. Specific COVID-19-related symptoms were identified in 7 patients (35%). Among the 12 health care workers infected, 1 developed a bilateral mild-grade interstitial pneumonia. COVID-19 infection after cardiac surgery, regardless the time of the onset, is a serious condition. The systemic inflammatory state that follows extracorporeal circulation may mask the typical COVID-19 laboratory findings, making the diagnosis more difficult. A strict reorganization of the hospital resources is necessary to safely resume the cardiac surgical activity.

Identifiants

pubmed: 33220960
pii: S0022-5223(20)32872-5
doi: 10.1016/j.jtcvs.2020.09.138
pmc: PMC7581347
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1085-1092.e3

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Références

Lancet Respir Med. 2020 Apr;8(4):e24
pubmed: 32178774
Eur J Cardiothorac Surg. 2020 Jun 1;57(6):1025-1028
pubmed: 32301984
Crit Care. 2020 May 8;24(1):205
pubmed: 32384917
Ann Thorac Surg. 1999 Sep;68(3):1107-15
pubmed: 10510030
Ann Thorac Surg. 2020 Aug;110(2):697-700
pubmed: 32305286
J Card Surg. 2020 Jun;35(6):1177-1179
pubmed: 32333437
Ann Thorac Surg. 2020 Nov;110(5):e405-e407
pubmed: 32333849
J Thorac Cardiovasc Surg. 1987 Jun;93(6):860-6
pubmed: 3494886
J Thorac Cardiovasc Surg. 2020 Oct;160(4):968-973
pubmed: 32505456
Int J Infect Dis. 2005 Nov;9(6):323-30
pubmed: 16095942
Ann Thorac Surg. 2007 Sep;84(3):823-8
pubmed: 17720383
Int J Cardiol. 2007 Aug 9;120(1):108-14
pubmed: 17141340
Signal Transduct Target Ther. 2020 Mar 27;5(1):33
pubmed: 32296069
Heart Surg Forum. 2020 Apr 21;23(2):E231-E233
pubmed: 32364920
Cell Mol Immunol. 2020 May;17(5):533-535
pubmed: 32203188
Can J Cardiol. 2020 Jul;36(7):971-976
pubmed: 32380228
Ann Thorac Surg. 1998 Mar;65(3):712-8
pubmed: 9527200
Clin Exp Immunol. 1999 Feb;115(2):315-23
pubmed: 9933459
J Cardiothorac Vasc Anesth. 2009 Apr;23(2):223-31
pubmed: 18930659
Eur J Cardiothorac Surg. 2003 Aug;24(2):260-9
pubmed: 12895618
Can J Anaesth. 1994 Sep;41(9):876-7
pubmed: 7525092

Auteurs

Khalil Fattouch (K)

Department of Cardiovascular Surgery, GVM Care & Research, Maria Eleonora Hospital, Palermo, Italy; GVM Care & Research, Maria Cecilia Hospital, Cotignola (RA), Italy.

Salvatore Corrao (S)

Department of Internal Medicine, National Relevance and High Specialization Hospital Trust ARNAS Civico, Di Cristina, Benfratelli, Palermo, Italy; Dipartimento di Promozione della Salute, Materno Infantile, Medicina Interna e Specialistica di Eccellenza "G. D'Alessandro", PROMISE, University of Palermo School of Medicine, Palermo, Italy.

Ettore Augugliaro (E)

Department of Cardiovascular Surgery, GVM Care & Research, Maria Eleonora Hospital, Palermo, Italy.

Alberto Minacapelli (A)

Department of Cardiovascular Surgery, GVM Care & Research, Maria Eleonora Hospital, Palermo, Italy.

Angela Nogara (A)

Department of Cardiovascular Surgery, GVM Care & Research, Maria Eleonora Hospital, Palermo, Italy.

Giulia Zambelli (G)

Department of Cardiovascular Surgery, GVM Care & Research, Maria Eleonora Hospital, Palermo, Italy.

Christiano Argano (C)

Department of Internal Medicine, National Relevance and High Specialization Hospital Trust ARNAS Civico, Di Cristina, Benfratelli, Palermo, Italy.

Marco Moscarelli (M)

Department of Cardiovascular Surgery, GVM Care & Research, Maria Eleonora Hospital, Palermo, Italy; GVM Care & Research, Maria Cecilia Hospital, Cotignola (RA), Italy. Electronic address: m.moscarelli@imperial.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH